Leading science, pioneering therapies

CRM Publications

Found 509 results
Filters: Keyword is Humans  [Clear All Filters]
2013
Münzel EJolanda, Wimperis JZ, Williams AC.  2013.  Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.BMJ Case Rep. 2013
Stefańska A, Stefańska A, Péault B, Péault B, Mullins JJ, Mullins JJ.  2013.  Renal pericytes: multifunctional cells of the kidneys.Pflugers Arch. 465(6):767-73.
Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A.  2013.  Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection.Cell. 152(1-2):51-67.
Festuccia N, Osorno R, Wilson V, Chambers I.  2013.  The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states.Curr Opin Genet Dev. 23(5):504-11.
Bell CH, Healey E, van Erp S, Bishop B, Tang C, Gilbert RJC, A Aricescu R, R Pasterkamp J, Siebold C.  2013.  Structure of the repulsive guidance molecule (RGM)-neogenin signaling hub.Science. 341(6141):77-80.
Gerlach JQ, Krüger A, Gallogly S, Hanley SA, Hogan MC, Ward CJ, Joshi L, Griffin MD.  2013.  Surface glycosylation profiles of urine extracellular vesicles.PLoS One. 8(9):e74801.
Morgani SM, Canham MA, Nichols J, Sharov AA, Migueles RPortero, Ko MSH, Brickman JM.  2013.  Totipotent embryonic stem cells arise in ground-state culture conditions.Cell Rep. 3(6):1945-57.
Crisan M.  2013.  Transition of mesenchymal stem/stromal cells to endothelial cells.Stem Cell Res Ther. 4(4):95.
Barateiro A, Miron VE, Santos SD, Relvas JB, Fernandes A, ffrench-Constant C, Brites D.  2013.  Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination.Mol Neurobiol. 47(2):632-44.
Soufi A, Zaret KS.  2013.  Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.Cell Cycle. 12(10):1487-91.
Bilican B, Serio A, Shaw CE, Maniatis T, Chandran S.  2013.  Unpicking neurodegeneration in a dish with human pluripotent stem cells: one cell type at a time.Cell Cycle. 12(15):2339-40.
Borooah S, Phillips MJ, Bilican B, Wright AF, Wilmut I, Chandran S, Gamm D, Dhillon B.  2013.  Using human induced pluripotent stem cells to treat retinal disease.Prog Retin Eye Res. 37:163-81.
Bellamy COC, R Maxwell S, Prost S, Azodo IA, Powell JJ, Manning JR.  2013.  The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre.Histopathology. 62:431–445.
Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P et al..  2013.  Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.Genes Dev. 27(6):654-69.
2012
James AW, Zara JN, Corselli M, Askarinam A, Zhou AM, Hourfar A, Nguyen A, Megerdichian S, Asatrian G, Pang S et al..  2012.  An abundant perivascular source of stem cells for bone tissue engineering.Stem Cells Transl Med. 1(9):673-84.
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du M-Q, Luan S-L, Altmann DR, Thompson AJ et al..  2012.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.Lancet Neurol. 11(2):150-6.
Russell AP, Crisan M, Léger B, Corselli M, McAinch AJ, O'Brien PE, Cameron-Smith D, Péault B, Casteilla L, Giacobino J-P.  2012.  Brown adipocyte progenitor population is modified in obese and diabetic skeletal muscle.Int J Obes (Lond). 36(1):155-8.
Falk A, Koch P, Kesavan J, Takashima Y, Ladewig J, Alexander M, Wiskow O, Tailor J, Trotter M, Pollard SM et al..  2012.  Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons.PLoS One. 7(1):e29597.
Chinn IK, C Blackburn C, Manley NR, Sempowski GD.  2012.  Changes in primary lymphoid organs with aging.Semin Immunol. 24(5):309-20.
Kumar R, Rodriguez V, Matsumoto JMS, Khan SP, Weaver AL, McBane RD, Heit JA.  2012.  Development and initial validation of a questionnaire to diagnose the presence and severity of post-thrombotic syndrome in children.Pediatr Blood Cancer. 58(4):643-4.
Ruetz T, Lin AEn-Ju, Guttman JAndrew.  2012.  Enterohaemorrhagic Escherichia coli requires the spectrin cytoskeleton for efficient attachment and pedestal formation on host cells.Microb Pathog. 52(3):149-56.
Soufi A, Donahue G, Zaret KS.  2012.  Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.Cell. 151(5):994-1004.
Kan AA, van Erp S, Derijck AAHA, de Wit M, Hessel EVS, O'Duibhir E, de Jager W, Van Rijen PC, Gosselaar PH, de Graan PNE et al..  2012.  Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response.Cell Mol Life Sci. 69(18):3127-45.
Devoy A, Bunton-Stasyshyn RKA, Tybulewicz VLJ, Smith AG, Fisher EMC.  2012.  Genomically humanized mice: technologies and promises.Nat Rev Genet. 13(1):14-20.
Danovi D, Folarin AA, Baranowski B, Pollard SM.  2012.  High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.Methods Enzymol. 506:311-29.

Pages